RPG Life Sciences posts Q2 FY25 revenue Up by 12% YoY
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
Revenue from operations registered a growth of 12% Y-o-Y at Rs 337.63 crores for H1 FY25
The newly setup entity, Emcutix Biopharmaceuticals Limited, plans to significantly expand Emcure’s offerings
Silica is a proven and highly effective anti-caking agent that has been used for decades
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
This transaction is the third acquisition by three different Japanese players in this segment
Experienced commercial leader takes helm to expand cardiovascular diagnostic company globally and commercialize company’s flagship plaque analysis software
KIMS already have a multi-specialty hospital and gastro unit at Vizag
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
The product is bioequivalent and therapeutically equivalent to the Reference Listed Drug (RLD) Neurontin Tablets, 600 mg and 800 mg, of Viatris Specialty
Subscribe To Our Newsletter & Stay Updated